CytA, a reductase in the cytorhodin biosynthesis pathway, inactivates anthracycline drugs in Streptomyces
Open Access
- 6 December 2019
- journal article
- research article
- Published by Springer Nature in Communications Biology
- Vol. 2 (1) , 1-9
Abstract
Antibiotic-producing microorganism can develop strategies to deal with self-toxicity. Cytorhodins X and Y, cosmomycins A and B, and iremycin, are produced as final products from a marine-derived Streptomyces sp. SCSIO 1666. These C-7 reduced metabolites show reduced antimicrobial and comparable cytotoxic activities relative to their C-7 glycosylated counterparts. However, the biosynthetic mechanisms and relevant enzymes that drive C-7 reduction in cytorhodin biosynthesis have not yet been characterized. Here we report the discovery and characterization of a reductase, CytA, that mediates C-7 reduction of this anthracycline scaffold; CytA endows the producer Streptomyces sp. SCSIO 1666 with a means of protecting itself from the effects of its anthracycline products. Additionally, we identified cosmomycins C and D as two intermediates involved in cytorhodin biosynthesis and we also broadened the substrate specificity of CytA to clinically used anthracycline drugs.Keywords
Funding Information
- National Natural Science Foundation of China (81425022, U1501223, 41476133)
This publication has 28 references indexed in Scilit:
- Cosmomycin C inhibits signal transducer and activator of transcription 3 (STAT3) pathways in MDA-MB-468 breast cancer cellBioorganic & Medicinal Chemistry, 2011
- Aclacinomycin oxidoreductase (AknOx) from the biosynthetic pathway of the antibiotic aclacinomycin is an unusual flavoenzyme with a dual active siteProceedings of the National Academy of Sciences, 2007
- Analyses of the Molecular Mechanism of Adriamycin-Induced CardiotoxicityFree Radical Biology and Medicine, 1997
- The new cytotoxic antibiotic cytorhodin X, an unusual anthracyclinone-9.ALPHA.-glycoside.The Journal of Antibiotics, 1992
- Anthracycline metabolites from Streptomyces violaceus A262. II. New anthracycline epelmycins produced by a blocked mutant strain SU2-730.The Journal of Antibiotics, 1991
- Anthracycline metabolites from Streptomyces violaceus A262. I. Isolation of antibiotic-blocked mutants from Streptomyces violaceus A262.The Journal of Antibiotics, 1991
- Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assaysJournal of Immunological Methods, 1983
- Spectroscopic observation of the tautomer of 7-deoxydaunomycinone from elimination of daunosamine from daunomycin hydroquinoneJournal of the American Chemical Society, 1983
- New anthracycline antibiotics produced by interspecific recombinants of streptomycetes. III. Isolation and structure of iremycin.The Journal of Antibiotics, 1980
- Reductive microbial conversion of anthracycline antibioticsBiochemistry, 1976